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S1 Analytical analysis using LC-MS/MS
MPs and target transformation products (TPs) (Table S1 ) in culture supernatant were first cleaned by automated online SPE, and then analyzed using reversed-phase liquid chromatography coupled to a high-resolution quadrupole orbitrap mass spectrometer (QExactive, Thermo Scientific). The online-SPE procedure involved three steps: loading, enrichment, and elution as described previously. 1 In detail, 20 mL diluted sample or standard with internal standard mix-stock (200 µL sample or standard + 100 µL of µg/L internal standard mix-stock + 19.7 mL nanopure water) was loaded with two times of 10 mL via a dispenser syringe. A selfmade mixed-bed multilayer extraction cartridge and two six-port valves were used for sample 
S2 Sorption and abiotic biotransformation experiments
In order to evaluate the sorption effects of CaCO 3 precipitates in the medium matrix and abiotic degradation of MP, the same setup as the biotransformation experiment described in the main 
S4 Estimation of first-order kinetics parameters
To compare biotransformation activities among different biological samples, we considered several existing cometabolic models 2, 3 . We found the reductant model and the competition model suitable for MIA-and RAN-added cultures, respectively (see equations in Table S3 ). In this study, ammonium was provided as unlimited substrate (S g >> K g ) by semicontinuous addition, except for the minimal ammonium samples (Lo_NH4), and we observed a nearly constant ammonium turnover rate without decrease for both MIA and RAN (Fig 3B) .
Given that, the dependence of MP concentration on ammonia concentration in the reductant and inhibition models can be neglected over the entire time course, if we assume K c >> S c or (1 + ) ≫ , it is thus simplified as first-order model. Therefore, a first-order model describing the contribution of all three processes to the observed decrease of the aqueous concentration of individual MPs was adopted as described previously 4, 5 , as well as in the main text. The fitting quality was evaluated by plotting measured data against model predictions including 90% credibility intervals and by the root-mean square errors (Fig. S7 ). 
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S6 Structure elucidation of MIA TP279, RAN TP273, TP289 and TP303
There are five tentative structures for TP279 ( Figure S9A Figure S10A&D ). Therefore, TP279 should be one of the four oxo MIA structures. We assumed that MIA TP279 should share similar MS 2 fragments with its corresponding oxo MIR analogue, as we observed for MIA and its analogue MIR that fragment pairs (i.e. m/z 234/235, 222/223, 208/209, the mass difference was due to the change from 6-C in MIA to 6-N in MIR) were detected ( Figure S10E&F ). Since 10-oxo MIR had a completely different fragmentation from TP279, the 10-oxo MIA structure is excluded ( Figure S10C ). 
CO
Structures of RAN TP273, TP289, and TP303 were also elucidated from MS 2 spectra. The chromatogram, MS and MS 2 spectra, formula, proposed structure, as well as structure interpretation for each of the three TPs are included in Fig. S11 . A biotransformation pathway is proposed accordingly as shown in Fig. S12 , which can occur biologically. The formula and structures of the intermediates present no conflict with MS 2 fragments in Figure S11 . 
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Additional Evidence for Structure Interpretation
The MS 2 fragment at the nominal mass 138 as well as the neutral loss of C 2 H 7 N was observed for RAN as well as for the RAN_TP_273.1263_3.2 and indicate that the substructure shown at nominal mass 138 is also a part of this TP. The MS 2 fragment at the nominal mass 118 indicates that the remaining atoms are connected. The structural evidence for this TP are similar to the ones for RAN_TP_273.1263_3.2, except that this TP consists of one extra oxygen atom and that a neutral loss of H 2 O can be observed multiple times. The occurrence of this neutral loss between the MS 2 fragments with the nominal mass 118 and 100 indicates that a hydroxyl moiety might be present in the remaining, undefined part of the molecule. The MS 2 fragment at the nominal mass 72 belongs most likely to the undefined part and was also observed for RAN_TP_273.1263_3.2. The neutral loss between the MS 2 fragment at the nominal mass 118 and 72 is CH 2 O 2 . This indicates that the undefined part of C 4 H 8 NO 3 can be fragmented into two parts consisting of C 3 H 6 ON and CH 2 O 2 . The detailed structure of the remaining part, however, remains unknown. Attributed Reaction from the Parent Compound to this TP It was not possible to assign a reaction to this parent TP pair. 
The MS 2 fragment at the nominal mass 138 as well as the neutral loss of C 2 H 7 N was observed for RAN as well as for RAN_TP_273.1263_3.2 and RAN_TP_289.1212_3.7, indicating that the substructure shown at nominal mass 138 is part of this TP. The MS 2 fragment at the nominal mass 132 indicates that the remaining atoms are connected. The structural evidence for this TP is similar to the one for RAN_TP_273.1263_3.2 and RAN_TP_289.1212_3.7, except that this TP consists of either an O atom or a CH 2 O more and that a neutral loss of CH 4 O can be observed multiple times. The occurrence of this neutral loss between the MS 2 fragments with the nominal mass 132 and 100 indicates that this moiety is present at the remaining, undefined part of the molecule. The MS 2 fragment at the nominal mass 72 most likely belongs to the undefined part of the molecule. The neutral loss between the MS 2 fragment at the nominal mass 132 and 72 is C 2 H 4 O 2 . This indicates that the undefined part of C 5 H 10 NO 3 can be fragmented into two parts consisting of C 3 H 6 ON and C 2 H 4 O 2 . The detailed structure of the remaining part, however, remains unknown. Attributed Reaction from the Parent Compound to this TP It was not possible to assign a reaction to this parent TP pair. Figure S11 . Structure elucidation of three RAN TP candidates identified from nontarget analysis.
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Figure S12 Hypothesized RAN biotransformation pathways.
S7 Proteomic analysis of N. gargensis during MIA and RAN biotransformation
Cell pellets were resuspended in 8 M urea/ 2 M thiourea buffer and sonicated (three cycles of 30 s, amplitude 0.7, power 70%) on-ice. After centrifugation, the pellets and the supernatant were collected separately. The pellets were resuspended in solubilization buffer [1% (w/v) Digitonin (AppliChem, Darmstadt, Germany), 300 mM NaCl, 100 mM Tris-HCl, pH 7.5] for membrane protein extraction. The extracted membrane proteins combined with the previous supernatant were precipitated using ice-cold acetone. The resulting protein pellets were subjected to SDS-PAGE. Each sample lane was then cut into one gel band and prepared for proteolytic cleavage. Protein lysate was reduced (2.5 mM DTT for 1 h at 60°C) and alkylated (10 mM iodacetamide for 30 min at 37°C). Proteolysis was performed overnight using trypsin (Promega, Madison, WI, USA) with an enzyme/substrate ratio of 1:25 at 37°C. Peptide lysates were extracted from the gel and desalted using C 18 ZipTips (Merck Millipore, Darmstadt, Germany).
The peptide lysates were separated on a UHPLC system (Ultimate 3000, Dionex/Thermo Fisher Scientific, Idstein, Germany). Five µL samples were first loaded for 5 min on the precolumn (µ-precolumn, cartridge column, 3 µm particle size, 75 µm inner diameter, 2 cm, C18, were considered as identified.
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The abundance of one detected protein was quantified using the average abundance of the top-3 peptide assigned to this protein. Partial least squares regression (PLS) was used to examine global differences of the normalized, log-transformed protein abundance profiles between the four groups (three MPs + ammonium, ammonium only) using the "plsr()" command from the "pls" library in R (Mevik and Wehrens, 2007) . 7 Cluster significance was tested using label permutation and the Dunn index. Clustering by groups was found to show a trend but not statistically significant (p = 0.107).
This is evidence that total protein profiles of N. gargenesis are not significantly different between the different treatments, consistent with the lack of differential expression of individual genes. 
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